T. Germain

2.3k total citations · 2 hit papers
15 papers, 1.8k citations indexed

About

T. Germain is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, T. Germain has authored 15 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Otorhinolaryngology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in T. Germain's work include Head and Neck Cancer Studies (8 papers), Cancer Diagnosis and Treatment (3 papers) and Kidney Stones and Urolithiasis Treatments (2 papers). T. Germain is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Cancer Diagnosis and Treatment (3 papers) and Kidney Stones and Urolithiasis Treatments (2 papers). T. Germain collaborates with scholars based in France and United States. T. Germain's co-authors include É. Bardet, B. Rhein, M. Alfonsi, G. Calais, J. Tortochaux, C. Sire, Philippe Bergerot, P. Oudinot, Philippe B. Bertrand and P. Garaud and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

T. Germain

15 papers receiving 1.7k citations

Hit Papers

Randomized Trial of Radiation Therapy Versus Concomitant ... 1999 2026 2008 2017 1999 2003 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Germain France 8 1.5k 1.1k 694 598 121 15 1.8k
B. Rhein France 11 1.9k 1.2× 1.3k 1.2× 852 1.2× 741 1.2× 180 1.5× 19 2.2k
Philippe Bergerot France 9 1.6k 1.1× 1.2k 1.1× 872 1.3× 629 1.1× 144 1.2× 13 2.0k
J.-L. Lefebvre France 16 1.4k 0.9× 1.1k 1.0× 671 1.0× 690 1.2× 79 0.7× 29 1.8k
C. Sire France 13 2.2k 1.5× 1.5k 1.4× 1.0k 1.5× 895 1.5× 142 1.2× 23 2.5k
Kie-Kian Ang United States 5 1.2k 0.8× 833 0.8× 536 0.8× 541 0.9× 112 0.9× 5 1.5k
W. Dobrowsky Austria 17 985 0.6× 793 0.7× 690 1.0× 512 0.9× 183 1.5× 55 1.6k
P. Oudinot France 6 939 0.6× 662 0.6× 443 0.6× 377 0.6× 77 0.6× 11 1.1k
Louis Portugal United States 19 903 0.6× 731 0.7× 402 0.6× 473 0.8× 57 0.5× 43 1.3k
J.F. Greskovich United States 20 514 0.3× 480 0.4× 756 1.1× 390 0.7× 121 1.0× 70 1.2k
Karen Bénézery France 25 796 0.5× 937 0.9× 766 1.1× 431 0.7× 195 1.6× 93 1.8k

Countries citing papers authored by T. Germain

Since Specialization
Citations

This map shows the geographic impact of T. Germain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Germain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Germain more than expected).

Fields of papers citing papers by T. Germain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Germain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Germain. The network helps show where T. Germain may publish in the future.

Co-authorship network of co-authors of T. Germain

This figure shows the co-authorship network connecting the top 25 collaborators of T. Germain. A scholar is included among the top collaborators of T. Germain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Germain. T. Germain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Germain, T., et al.. (2022). À quelle vitesse peut-on traiter un calcul complexe en mini-percutané ?. Progrès en Urologie. 32(6). 451–457. 1 indexed citations
3.
Calais, G., S. Chapet, Y. Pointreau, et al.. (2010). Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma: Ten-year results of the 94-01 GORTEC randomized study.. Journal of Clinical Oncology. 28(15_suppl). 5516–5516. 1 indexed citations
4.
Bourgeois, Hugues, et al.. (2004). Phase I Study With Dose Escalation of Gemcitabine and Cisplatin in Combination With Ifosfamide (GIP) in Patients With Non–Small-Cell Lung Carcinoma. American Journal of Clinical Oncology. 27(1). 89–95. 6 indexed citations
5.
Denis, Fabrice, P. Garaud, É. Bardet, et al.. (2003). Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx Carcinoma. Journal of Clinical Oncology. 22(1). 69–76. 673 indexed citations breakdown →
6.
Denis, Fabrice, P. Garaud, É. Bardet, et al.. (2002). Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. International Journal of Radiation Oncology*Biology*Physics. 55(1). 93–98. 170 indexed citations
7.
Calais, G., M. Alfonsi, É. Bardet, et al.. (2001). Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma. final results of the 94-01 GORTEC randomized study. International Journal of Radiation Oncology*Biology*Physics. 51(3). 1–2. 9 indexed citations
8.
Denis, Fabrice, M. Alfonsi, É. Bardet, et al.. (2001). Late toxicity results of randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma (GORTEC 94-01). International Journal of Radiation Oncology*Biology*Physics. 51(3). 39–39. 4 indexed citations
9.
Calais, G., M. Alfonsi, É. Bardet, et al.. (2000). [Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy].. PubMed. 87 Spec No. 48–53. 25 indexed citations
10.
Calais, G., M. Alfonsi, É. Bardet, et al.. (1999). Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma. JNCI Journal of the National Cancer Institute. 91(24). 2081–2086. 842 indexed citations breakdown →
11.
Millot, Frédéric, B. Bataille, P Babin, et al.. (1999). High-dose chemotherapy with hematopoietic stem cell transplantation in adults with bone marrow relapse of medulloblastoma: report of two cases. Bone Marrow Transplantation. 24(12). 1347–1349. 11 indexed citations
12.
Haith, Linwood R., et al.. (1998). Trilaminar Skin Coverage Combined with Cultured Epithelial Autografts???A New Technique for Treating the Elderly Patient with Burn Injuries. Journal of Burn Care & Rehabilitation. 19(1). 59–61. 3 indexed citations
13.
Patton, Mary Lou, et al.. (1995). Barium and fecal impaction: an unusual case of bilateral hydronephrosis.. PubMed. 61(8). 709–13. 16 indexed citations
14.
Patton, Mary Lou, et al.. (1994). Use of percutaneous endoscopic gastrostomy tubes in burn patients. Surgical Endoscopy. 8(9). 1067–1071. 9 indexed citations
15.
Chauvergne, J, et al.. (1982). [Treatment of inflammatory breast cancer. Controlled study of a combination therapy program].. PubMed. 58(32). 1813–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026